Literature DB >> 25846854

Life expectancy in bipolar disorder.

Lars Vedel Kessing1, Eleni Vradi2, Per Kragh Andersen2.   

Abstract

OBJECTIVE: Life expectancy in patients with bipolar disorder has been reported to be decreased by 11 to 20 years. These calculations are based on data for individuals at the age of 15 years. However, this may be misleading for patients with bipolar disorder in general as most patients have a later onset of illness. The aim of the present study was to calculate the remaining life expectancy for patients of different ages with a diagnosis of bipolar disorder.
METHODS: Using nationwide registers of all inpatient and outpatient contacts to all psychiatric hospitals in Denmark from 1970 to 2012 we calculated remaining life expectancies for values of age 15, 25, 35 ⃛ 75 years among all individuals alive in year 2000.
RESULTS: For the typical male or female patient aged 25 to 45 years, the remaining life expectancy was decreased by 12.0-8.7 years and 10.6-8.3 years, respectively. The ratio between remaining life expectancy in bipolar disorder and that of the general population decreased with age, indicating that patients with bipolar disorder start losing life-years during early and mid-adulthood.
CONCLUSIONS: Life expectancy in bipolar disorder is decreased substantially, but less so than previously reported. Patients start losing life-years during early and mid-adulthood.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  age; bipolar disorder; gender; life expectancy; mania; mortality

Mesh:

Year:  2015        PMID: 25846854     DOI: 10.1111/bdi.12296

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  29 in total

1.  Childhood Maltreatment in Bipolar Disorders.

Authors:  Bruno Etain; Monica Aas
Journal:  Curr Top Behav Neurosci       Date:  2021

2.  Differences in psychomotor activity and heart rate variability in patients with newly diagnosed bipolar disorder, unaffected relatives, and healthy individuals.

Authors:  Josefine Freyberg; Søren Brage; Lars Vedel Kessing; Maria Faurholt-Jepsen
Journal:  J Affect Disord       Date:  2020-01-23       Impact factor: 4.839

Review 3.  Targeting the immune system in the treatment of bipolar disorder.

Authors:  Joshua D Rosenblat
Journal:  Psychopharmacology (Berl)       Date:  2019-02-13       Impact factor: 4.530

4.  Diagnosis and Treatment of Bipolar Illness in the Primary Care Office.

Authors:  Jay A Brieler; Elizabeth Keegan-Garrett
Journal:  Mo Med       Date:  2022 May-Jun

5.  Associations between circadian misalignment and telomere length in BD: an actigraphy study.

Authors:  Luana Spano; Vincent Hennion; Cynthia Marie-Claire; Frank Bellivier; Jan Scott; Bruno Etain
Journal:  Int J Bipolar Disord       Date:  2022-05-27

6.  Twenty-year progression of body mass index in a county-wide cohort of people with schizophrenia and bipolar disorder identified at their first episode of psychosis.

Authors:  Martin Strassnig; Roman Kotov; Danielle Cornaccio; Laura Fochtmann; Philip D Harvey; Evelyn J Bromet
Journal:  Bipolar Disord       Date:  2017-06-02       Impact factor: 6.744

7.  Long-term Changes in Cognitive Functioning in Individuals With Psychotic Disorders: Findings From the Suffolk County Mental Health Project.

Authors:  Anne-Kathrin J Fett; Eva Velthorst; Abraham Reichenberg; Camilo J Ruggero; Jennifer L Callahan; Laura J Fochtmann; Gabrielle A Carlson; Greg Perlman; Evelyn J Bromet; Roman Kotov
Journal:  JAMA Psychiatry       Date:  2020-04-01       Impact factor: 21.596

8.  The association between self-reported physical activity and objective measures of physical activity in participants with newly diagnosed bipolar disorder, unaffected relatives, and healthy individuals.

Authors:  Josefine Freyberg; Søren Brage; Lars Vedel Kessing; Maria Faurholt-Jepsen
Journal:  Nord J Psychiatry       Date:  2020-10-14       Impact factor: 2.202

9.  Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study).

Authors:  Lumbini Azim; Paul Hindmarch; Georgiana Browne; Thomas Chadwick; Emily Clare; Paul Courtney; Lyndsey Dixon; Nichola Duffelen; Tony Fouweather; John R Geddes; Nicola Goudie; Sandy Harvey; Timea Helter; Eva-Maria Holstein; Garry Martin; Phil Mawson; Jenny McCaffery; Richard Morriss; Judit Simon; Daniel Smith; Paul R A Stokes; Jenn Walker; Chris Weetman; Faye Wolstenhulme; Allan H Young; Stuart Watson; R Hamish McAllister-Williams
Journal:  BMC Psychiatry       Date:  2021-07-05       Impact factor: 3.630

10.  A composite peripheral blood gene expression measure as a potential diagnostic biomarker in bipolar disorder.

Authors:  K Munkholm; L Peijs; M Vinberg; L V Kessing
Journal:  Transl Psychiatry       Date:  2015-08-04       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.